Characterization of a common susceptibility locus for asthma-related traits
Laitinen, T., Polvi, A., Rydman, P., Vendelin, J., Pulkkinen, V., Salmikangas, P., M'kel', S., Rehn, M., Pirskanen, A., Rautanen, A., Zucchelli, M., Gullst'n, H., Leino, M., Alenius, H., Pet'ys, T., Haahtela, T., Laitinen, A., Laprise, C., Hudson, T. J., Laitinen, L. A., and Kere, J. (2004) Characterization of a common susceptibility locus for asthma-related traits Science 304, 300-304
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice
Rizzi, A., Vergura, R., Marzola, G., Ruzza, C., Guerrini, R., Salvadori, S., Regoli, D., and Calo, G. (2008) Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice Br. J. Pharmacol. 154 (2) 471-479
Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice
Pa'eda, C., Huitron-Resendiz, S., Frago, L.-M., Chowen, J.-A., Picetti, R., de Lecea, L., and Roberts, A.-J. (2009) Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice J. Neurosci. 29 (13) 4155-4161
(2009)J. Neurosci., vol.29, Issue.13, pp. 4155-4161
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: Identification of potent and pure neuropeptide S receptor antagonists
Guerrini, R., Camarda, V., Trapella, C., Calo, G., Rizzi, A., Ruzza, C., Fiorini, S., Marzola, E., Reinscheid, R.-K., Regoli, D., and Salvadori, S. (2009) Synthesis and biological activity of human neuropeptide S analogues modified in position 5: Identification of potent and pure neuropeptide S receptor antagonists J. Med. Chem. 52 (2) 524-529
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S
Camarda, V., Rizzi, A., Ruzza, C., Zucchini, S., Marzola, G., Marzola, E., Guerrini, R., Salvadori, S., Reinscheid, R.-K., Regoli, D., and Calo, G. (2009) In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S J. Pharmacol. Exp. Ther. 328 (2) 549-555
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists
Guerrini, R., Camarda, V., Trapella, C., Calo, G., Rizzi, A., Ruzza, C., Fiorini, S., Marzola, E., Reinscheid, R.-K., Regoli, D., and Salvadori, S. (2009) Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists J. Med. Chem. 52 (13) 4068-4071
(2009)J. Med. Chem., vol.52, Issue.13, pp. 4068-4071
Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor
Okamura, N., Habay, S.-A., Zeng, J., Chamberlin, A.-R., and Reinscheid, R.-K. (2008) Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor J. Pharmacol. Exp. Ther. 325 (3) 893-901
Identifying structural features on 1,1-diphenylhexahydrooxazolo[3,4-a] pyrazin-3-ones critical for neuropeptide S antagonist activity
Zhang, Y., Gilmour, B.-P., Navarro, H.-A., and Runyon, S.-P. (2008) Identifying structural features on 1,1-diphenylhexahydrooxazolo[3,4-a]pyrazin-3- ones critical for neuropeptide S antagonist activity Bioorg. Med. Chem. Lett. 18 (14) 4064-4067
Sato, S., Shintani, Y., Miyajima, N., and Yoshimura, K. (2002) Novel G protein-coupled receptor protein and DNA thereof, World Patent Application WO 02/31145 A1.
A multiplex calcium assay for identification of GPCR agonists and antagonists
in press
Liu, K., Southall, N., Titus, S. A., Inglese, J., Eskay, R. L., Shinn, P., Austin, C. P., Heilig, M. A., and Zheng, W. (2010) A multiplex calcium assay for identification of GPCR agonists and antagonists. Assay Drug Dev. Technol., in press.